How are peptide therapies administered
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 99.99% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
A key challenge lies in the methods for large-scale production and quality control of MSCs, which are crucial to ensuring the safety and efficacy of cell therapies
A critical real-world evidence (RWE) appraisal of these cohorts reveals significant limitations
Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
This confusion has resulted not only in some innocent, but incorrect conclusions in research papers and reviews (Weiner, McKim, and Blakemore 2017 Weiner, M